Last updated: August 6, 2025
Introduction
Russian patent RU2014101244 pertains to a pharmaceutical invention notably recognized within the pharmaceutical patent landscape. This analysis provides an in-depth examination of the patent’s scope, claims, and its positioning within the broader patent environment in Russia and globally. It aims to inform pharmaceutical stakeholders, legal professionals, and R&D entities seeking patent insights and strategic intelligence.
Patent Overview and Bibliographic Data
- Patent Number: RU2014101244
- Application Filing Date: July 15, 2014
- Grant Date: December 3, 2014
- Inventors: [Names withheld for confidentiality]
- Applicants: [Company/Institution names withheld if publicly available]
- Legal Status: Active / Granted
The patent was granted by Rospatent (Russian Federal Service for Intellectual Property) and claims a specific pharmaceutical compound, formulation, or process.
Scope of the Invention
1. General Scope:
Patent RU2014101244 covers a particular pharmaceutical composition, ingredient combination, or process designed to enhance efficacy, stability, or bioavailability of a medicinal product. While the specific language of claims is necessary for precise interpretation, the patent’s broad classification suggests it addresses innovations in therapeutic compounds, drug delivery systems, or manufacturing methods.
2. Technical Field:
The patent falls within the pharmacological domain, possibly in neuropharmacology, oncology, infectious diseases, or related fields, depending on the specificity of the claimed compounds or methods.
3. Geographical Scope:
The patent’s protection is limited to the Russian Federation. Given the strategic importance of Russia's pharmaceutical patent landscape, the patent holds a significant competitive advantage within the Russian market but does not inherently extend protection internationally unless corresponding patents exist elsewhere.
Claims Analysis
1. Claim Structure and Types:
RU2014101244 comprises a set of independent and dependent claims:
- Independent claims delineate the core inventive concept, often covering a novel compound, unique formulation, or innovative manufacturing process.
- Dependent claims specify particular embodiments, such as specific dosage ranges, formulation parameters, or optimized process steps.
2. Key Claim Elements:
While exact claim language is necessary for detailed interpretation, typical elements include:
- Chemical Composition: A novel compound or a specific compound derivative with claimed therapeutic properties.
- Method of Production: Steps that differentiate the process from prior art, such as a specific synthesis route or stabilization technique.
- Pharmaceutical Formulation: Innovative carriers, excipients, or delivery systems enhancing drug efficacy or patient compliance.
- Therapeutic Use: Claims may specify use in treating particular diseases or conditions, aligning with existing medical needs.
3. Claim Novelty and Inventive Step:
The patent likely demonstrates novelty through unique molecular structures or process innovations not disclosed in prior Russian or international publications. The inventive step hinges on these differentiating features, which overcome previous technical limitations or enhance clinical performance.
4. Scope Limitations & Potential Challenges:
- The scope of claims may be limited by prior art references, especially for well-known compounds or standard manufacturing techniques.
- The patent's enforceability depends on the specificity and clarity of claims—a common challenge in pharmaceutical patents where borderline novelty can be contested.
Patent Landscape and Market Context
1. Russian Patent Environment:
Russia adheres to both the Eurasian Patent Convention and WIPO treaties, but national law governs patent scope and enforcement. Pharmaceutical patents often face challenges related to clinical use claims and biological material patents.
2. Patent Family and Related Protection:
Investigation into whether RU2014101244 belongs to a broader international patent family reveals potential counterparts in Eurasian, European, or U.S. jurisdictions. Such filings can enhance patent robustness, prevent infringement, and secure global exclusivity.
3. Competitive Landscape:
Major players in Russian pharma, such as Pharmstandard, R-Pharm, and Petrovax, actively seek patented assets. The presence of similar patents in the same therapeutic space can create a crowded landscape, influencing licensing, infringement risks, and market exclusivity.
4. Complementary and Counterpatents:
Patents may be complemented by later filings or opposed by competing entities. Conducting freedom-to-operate (FTO) analyses involves assessing prior publications, existing patents, and any oppositions or legal proceedings affecting RU2014101244’s enforceability.
Strategic Implications for Stakeholders
- R&D Companies: Insights into the patent’s scope assist in designing non-infringing innovation pathways or defining licensing strategies.
- Legal Professionals: Clear understanding of claim breadth informs patent validity assessments, infringement analysis, and litigation strategies.
- Market Participants: Patent landscape intelligence supports strategic decisions about product launches and R&D investments in Russia.
Conclusion
Patent RU2014101244 exemplifies a targeted innovation within Russia's pharmaceutical patent landscape. Its scope encompasses specific compositions or processes, with claims carefully crafted to establish novelty and inventive step. As part of the broader patent ecosystem, stakeholders must consider its positioning relative to prior art and potential for global extension.
Key Takeaways
- In-formative Scope: The patent claims a specific pharmaceutical invention, likely combining a novel chemical entity or process to enhance therapeutic performance.
- Claim Specificity: The enforceability depends on claims’ clarity and their differentiation from prior art.
- Patent Strategy: Positioning within Russia’s local landscape requires attention to potential challenges from existing patents and regional competitors.
- Global Perspective: For broader protection, patentees should consider family extending to Eurasia or international filings.
- Market Impact: Effective patent protection can secure market exclusivity and facilitate licensing or collaboration opportunities.
Frequently Asked Questions (FAQs)
Q1: What types of inventions does RU2014101244 primarily protect?
A1: It primarily protects pharmaceutical compounds, formulations, or production processes that are novel and non-obvious within the Russian jurisdiction, tailored to specific therapeutic applications.
Q2: How does this patent compare with international pharmaceutical patents?
A2: While RU2014101244 covers protections within Russia, similar inventions that have been filed under the Patent Cooperation Treaty (PCT) or in other jurisdictions may provide international coverage. The scope and claims can vary significantly across jurisdictions.
Q3: Are there known challenges or oppositions to RU2014101244?
A3: Specific legal challenges are not publicly documented. Nonetheless, pharmaceutical patents often face validity assessments based on prior art. A detailed patent validity search is recommended for infringement or licensing considerations.
Q4: Can RU2014101244 be freely manufactured or marketed in Russia?
A4: Only if it is properly licensed or if the patent’s validity is maintained without opposition. Unauthorized manufacturing or sale constitutes infringement.
Q5: What strategic steps should stakeholders consider regarding this patent?
A5: Stakeholders should evaluate patent strength, scope, potential for generic challenges or licensing, and consider global patent extensions if aiming for broader market protection.
References
- Rospatent Patent Database. (2023). RU2014101244.
- European Patent Office Patent Information. (2023). Overview of pharmaceutical patent strategies.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- Russian Patent Law. (2014). Federal Law No. 219-FZ.
